Department of Laser Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Medical Supplies Center, Chinese PLA General Hospital, Beijing, 100853, China.
Virol J. 2020 Jul 13;17(1):104. doi: 10.1186/s12985-020-01383-1.
Cervical cancer is the fourth most common cancer in women. Early detection and diagnosis play an important role in secondary prevention of cervical cancer. This study aims to provide more information to develop an effective strategy for the prevention and control of cervical cancer in northern China.
A retrospective single-centre descriptive cross-sectional study was conducted in Chinese PLA General Hospital located in Beijing, covering the period from January 2009 to June 2019. The patients who underwent a polymerase chain reaction (PCR)-based HPV genotyping test and cervical pathological diagnosis were included. Furthermore, we limited the interval between the two examination within 180 days for the purpose of making sure their correlation to analyse their relationship. Moreover, the relationship between different cervical lesions and age as well as single/multiple HPV infection was assessed.
A total of 3134 patients were eligible in this study after HPV genotyping test and pathological diagnosis. Most of the patients (95%) were from northern China. Among the patients, 1745(55.68%) had high-grade squamous intraepithelial neoplasia (HSIL), 1354 (43.20%) had low-grade squamous intraepithelial neoplasia (LSIL) and 35 (1.12%) were Normal. The mean age was 42.06 ± 10.82(range, 17-79 years). The women aged 35-49 years accounted for the highest incidence rate. The top five most commonly identified HPV genotypes in each lesion class were as follows: HPV16, 58, 52, 31 and 51 in the class of HSIL; HPV16, 52, 58, 56 and 51 in the class of LSIL; HPV16, 31, 6,11, 52 and 58 in the class of normal. The frequencies of HPV single genotype infection and multiple genotypes infection were 55.26 and 34.18%, respectively. There was no difference in the attributable proportions of multiple genotypes infection amongst HSIL, LSIL and Normal.
In Northern China, HPV16 was the most dominant genotype in the patients with pathological examination. The peak age of the onset of HSIL was between 35 and 49 years of age. Infection with multiple HPV genotypes did not increase the risk of HSIL. Type-specific HPV prevalence and attribution proportion to cervical precancerous lesions should be taken into consideration in the development of vaccines and strategy for screening in this population.
宫颈癌是女性中第四常见的癌症。早期发现和诊断对宫颈癌的二级预防起着重要作用。本研究旨在为中国北方地区宫颈癌的预防和控制提供更多信息,以制定有效的策略。
在中国人民解放军总医院(北京)进行了一项回顾性单中心描述性横断面研究,研究期间为 2009 年 1 月至 2019 年 6 月。纳入接受聚合酶链反应(PCR)-基于 HPV 基因分型检测和宫颈病理诊断的患者。此外,我们将两次检查的间隔限制在 180 天以内,以确保它们之间的相关性,从而分析它们之间的关系。此外,还评估了不同宫颈病变与年龄以及单一/多种 HPV 感染之间的关系。
经过 HPV 基因分型检测和病理诊断,共有 3134 例患者符合纳入标准。大多数患者(95%)来自中国北方。其中 1745 例(55.68%)为高级别鳞状上皮内病变(HSIL),1354 例(43.20%)为低级别鳞状上皮内病变(LSIL),35 例(1.12%)为正常。平均年龄为 42.06±10.82(范围 17-79 岁)。35-49 岁的女性发病率最高。每个病变类别中最常见的五种 HPV 基因型如下:HSIL 类别中 HPV16、58、52、31 和 51;LSIL 类别中 HPV16、52、58、56 和 51;正常类别中 HPV16、31、6、11、52 和 58。HPV 单一基因型感染和多种基因型感染的频率分别为 55.26%和 34.18%。在 HSIL、LSIL 和正常组中,多重基因型感染的归因比例无差异。
在中国北方,HPV16 是病理检查患者中最主要的基因型。HSIL 发病的高峰年龄在 35-49 岁之间。感染多种 HPV 基因型不会增加 HSIL 的风险。在开发疫苗和该人群筛查策略时,应考虑特定 HPV 流行率和对癌前病变的归因比例。